Press Releases and Statements

The Consumer Healthcare Products Association Educational Foundation today released the following statement announcing the 2023 U.S. Self-Care Marketing Awards finalists. Winners will be announced at the Eighth Annual CHPA Educational Foundation Gala on November 15 at The Bellevue Hotel in Philadelphia. Specific awards will recognize the strategic innovation and marketing expertise of CHPA member companies in the OTC medicine, consumer medical device, and dietary supplement industries.

Today, the Consumer Healthcare Products Association (CHPA) submitted comments to the U.S. Food and Drug Administration (FDA) in response to a Citizen Petition from the Environmental Defense Fund (EDF) asking FDA to revoke the use of the colorant titanium dioxide (TiO2) in foods, including dietary supplements.

A recent national survey of adults conducted by the Bullfinch Group for CHPA further sheds light on consumer awareness, experiences, and perceptions of PE.

The Consumer Healthcare Products Association (CHPA) Educational Foundation and Family Dollar today announced the launch of a program to help Family Dollar shoppers make informed, educated choices about choosing and using over-the-counter (OTC) products and dietary supplements.

Bill proposes to make dietary supplements eligible expenses in FSA/HSA accounts, allowing consumers to use tax-preferred health savings to purchase wellness products.

Consumer Healthcare Products Association (CHPA) President and CEO Scott Melville today released the below statement following the U.S. Food and Drug Administration (FDA) approving Opill®

Consumer Healthcare Products Association (CHPA) President and CEO Scott Melville released the following statement today in response to the U.S. Food and Drug Administration’s

CHPA thanked U.S. Senator Bob Casey (D-Pa.) and U.S. Representatives Brendan Boyle (D-Pa.), Ashley Hinson (R-Iowa), and Bob Latta (R-Ohio) this week for their steadfast commitment to a healthy America and strong self-care industry. The June 20 event was held inside the Kennedy Caucus Room on Capitol Hill and was also attended by CHPA’s corporate members, Board of Directors, stakeholders, and other supporters.

CHPA President and CEO Scott Melville today released the below statement following the National Institutes of Health’s (NIH) announcement that Stefan M. Pasiakos, Ph.D., FACSM, will serve as the new director of its Office of Dietary Supplements (ODS).

CHPA Senior Vice President of Dietary Supplements Duffy MacKay today released the following statement in response to results from a recent trial finding that people ages 60 and older who took a daily multivitamin showed an estimated 3.1 fewer years of memory loss than those who took a placebo. These results are the second time a multivitamin clinical trial within the COcoa Supplement and Multivitamin Outcomes Study (COSMOS) reached the same conclusion.

The Consumer Healthcare Products Association (CHPA) today announced the appointment of Lisa Parks, RPh, to serve as its Senior Vice President of Regulatory & Scientific Affairs.

CHPA today released the below statement following a U.S. Food and Drug Administration (FDA) joint advisory committee meeting, which concluded that Opill®, a once-daily oral contraceptive, should be approved as the first oral contraceptive for use without a prescription: